Cardio Diagnostics Holdings, Inc. (CDIOW)
US — Healthcare Sector
Automate Your Wheel Strategy on CDIOW
With Tiblio's Option Bot, you can configure your own wheel strategy including CDIOW - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CDIOW
- Rev/Share 0.0112
- Book/Share 5.592
- PB 0.6563
- Debt/Equity 0.0562
- CurrentRatio 23.5482
- ROIC -0.607
- MktCap 6470683.0
- FreeCF/Share -3.2655
- PFCF -1.1394
- PE -1.0211
- Debt/Assets 0.0526
- DivYield 0
- ROE -0.7279
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 5
- P/B Score 5
- D/E Score 3
Recent Analyst Ratings
Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
---|---|---|---|---|---|---|---|
No ratings available. |
News
About Cardio Diagnostics Holdings, Inc. (CDIOW)
- IPO Date
- Website https://cardiodiagnosticsinc.com
- Industry Biotechnology
- CEO Meeshanthini V. Dogan
- Employees 13
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.